semaglutide appetite Friday briefing: Are appetite-suppressing drugs really a fast track to weight loss? | World news Semaglutide is not a shortcut,

Semaglutide and Long-Term Weight Loss One landmark trial, the STEP (Semaglutide Treatment Effect in People with Obesity) program, has yielded promising results

Intended for adults with a BMI of 30 or greater, or 27 or greater with a weight-related health issue, Wegovy is proven to help patients lose an average of 15% of their body weight over 68 weeks

The medication is self-administered, which means youll be injecting it yourself subcutaneously (under the skin)

This is metabolically optimal and improves body composition

GIP (Glucose-dependent Insulinotropic Polypeptide): Enhances insulin release in response to meals and synergizes with GLP-1 to improve metabolic response

it's your body's homeostatic response to calorie restriction